1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 11/07/22, Licensing Program Analyst (LPA), M. Yang arrived unannounced to conduct a Case Management - Health and Safety Inspection. LPA introduced self, stated the purpose of the visit and met with the Lenette Otero-Gross, Administrator and Samantha Torres, Health and Wellness Director.
The purpose of the visit is to address two incidents that was reported to the department. The first incident that occurred on 11/01/22 where R1 money went missing from resident’s apartment. Interviews were conducted and records were obtained for S1 and R1. The information provide will be reviewed; a follow up case management will be conducted if necessary.
LPA address the second incident where there was a medication error. It was reported that on 10/07/22, R2 received medication Digoxin for 0.5 tablet and should have been administered 1 tablet. R2 did not received for six days medication: Atorvastatin and Metoprolol. R2 did not received for three days medication: Eliquis and Ezetimibe.
A deficiency is being cited on the attached 809D in accordance to California Code of Regulations, Title 22, Division 6.
An exit interview was conducted, and a Plan of Correction was reviewed and developed with administrator. A copy of this report and appeal rights was provided to Administrator.
|